Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

Withdrawn NCT06969378

Empiric Pulsed Field Pulmonary Vein Isolation During Atrial Tachycardia Ablation in Adults With Congenital Heart Disease

Conditions: Atrial Fibrillation, Atrial Tachycardia, Atrial Flutter, Congenital Heart Disease, Pulmonary Vein Isolation, Pulsed Field Ablation, Catheter Ablation

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Phase: NA

Sponsor: Boston Children's Hospital

Summary

This is a prospective, single-arm intervention trial whereby we will test the safety and efficacy of performing pulmonary vein isolation (PVI) using pulsed field ablation (PFA) in adult patients with congenital heart disease (CHD) who are presenting for atrial tachycardia (AT) ablation.

Eligibility Criteria

Inclusion Criteria: * Adult patients (\>= 18 years of age) with repaired or unrepaired congenital heart disease and a history of sustained (\>30 seconds) AT Exclusion Criteria: * History of sustained AF and/or previous catheter or surgical pulmonary vein isolation.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06969378). StuddyBuddy aggregates publicly available trial information.